Domestic clinical trials planned for China’s mRNA Covid-19 vaccine

Chinese pharmaceutical companies that have developed a Covid-19 vaccine using advanced mRNA technology are planning to hold clinical trials in the southwestern provinces of Yunnan and Guangxi.The candidate vaccine, known as ARCoV and jointly developed by Walvax Biotechnology Co, Suzhou Abogen Biosciences and the Academy of Military Science, is set to become the first Chinese-developed mRNA vaccine to undergo phase 3 trials.The trial was registered in the Chinese government database on Wednesday…

Breaking news from the Washington Post

After a Tanzanian opposition leader’s arrest, hopes for a democratic turn fade

Breaking news from the Times of India

Yediyurappa’s trusted aide Basavaraj Bommai to be new Karnataka chief minister

Breaking news from New York Times

After Covid Diagnosis, a Conservative Radio Host Sends a New Message

Breaking news from South China Morning Post

US companies deflect tough questions over Beijing 2022 Winter Olympics

Breaking news from the Washington Post

After a Tanzanian opposition leader’s arrest, hopes for a democratic turn fade

Breaking news from the Times of India

Yediyurappa’s trusted aide Basavaraj Bommai to be new Karnataka chief minister

Breaking news from New York Times

After Covid Diagnosis, a Conservative Radio Host Sends a New Message

Breaking news from South China Morning Post

US companies deflect tough questions over Beijing 2022 Winter Olympics

Breaking news from the Telegraph

Explosion at German chemical complex leaves two dead and more than 30 injured

Breaking news from the Guardian

‘This is how I’m going to die’: police tell panel of trauma of Capitol attack

Breaking news from the Washington Post

Europeans increasingly frustrated as White House maintains Trump-era covid travel restrictions